NRx Pharmaceuticals
NRXP | NASDAQ
$2.15
-$0.04 (-1.83%)
At close: Nov 16, 2026, 4:00 PM ET
$2.18
+$0.03 (+1.40%)
After-hours:
Nov 16, 2026, 7:54 PM ET
-1.83%
(1D)No price chart data available for 1D timeframe.
Rating
46
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #366/1021 (Top 36%)
Key Statistics
Market Data
Market Cap $93.84M
1D Range
2.05 2.20
52W Range
1.68 4.62
Valuation (TTM)
PE -2.91
PB -552.00
EV/EBITDA -3.13
Valuation (NTM)
Forward PE 8.94
Forward PEG 0.18
Price Target $2.00
Cash Flow
FCF Yield -22.0%
SBC Adj. FCF Yield -22.5%
SBC Impact -2.1%
Margins
Gross Margin 32.7%
Operating Margin -588.2%
FCF Margin -609.0%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 43.2% |
16.8%
FCF 3Y | 5Y -18.1% |
29.0%
Returns
ROA -68.7%
ROE 168.7%
ROIC -1855.5%
Financial Health
Net Cash
$25.9M
Current Ratio 0.86
Interest Coverage -17.45
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product port...
Sector Healthcare
Industry Biotechnology
Employees 29
IPO Date Dec 4, 2017
Website www.nrxpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 16, 2026
EPS
-$0.05
Beat +76.47%
YoY:
+81.48% REV
$1.16M
Miss -9.83%
YoY:
+378.93%Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$2.00
Downside
-6.98%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove NRXP